Areas of Focus
- Tumor immune microenvironment regulation and cancer immunotherapy
- Innovative CAR-T cell construction and research
Work Experience
- 2006-present: East China Normal University, School of Life Sciences
- 2007-2009: Visiting Scholar, Texas A&M University Health Science Center, USA
Academic Background & Achievements
- 2001-2006: PhD in Biochemistry and Molecular Biology, East China Normal University
- 1997-2001: Bachelor in Biochemistry, Anhui University
- Awards: Shanghai Outstanding Academic/Technical Leader, Morning Light Scholar
Publications
- FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion, Zeda Zhao, Juliang Qin, Ying Qian, Chenshen Huang, Xiaohong Liu, Ning Wang, Liqin Li, Yuqing Chao, Binghe Tan, Na Zhang, Min Qian, Dali Li, Mingyao Liu, Bing Du*, 2024
- Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies, X. Chen, B. Tan, H. Xing, X. Zhao, Y. Ping, Z. Zhang, J. Huang, X. Shi, N. Zhang, B. Lin, W. Cao, X. Li, X. Zhang, L. Li, Z. Jiang, M. Zhang, W. Li, M. Liu, Bing Du*, Yi Zhang*, 2024
- LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment, Na Zhang, Xiaohong Liu, Juliang Qin, Yue Sun, Hao Xiong, Boxu Lin, Kexin Liu, Binghe Tan, Chenglin Zhang, Chenshen Huang, Shancheng Ren*, Mingyao Liu*, Bing Du*, 2023
Awards
- Shanghai Outstanding Academic/Technical Leader
- Morning Light Scholar
- East China Normal University Outstanding Communist Party Member
- East China Normal University Graduate Excellence Education Award
- East China Normal University Innovation and Entrepreneurship Excellent Instructor